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Abstract
Desmoid tumors are rare, benign fibroblastic tumors that are locally infiltrative and can cause
extensive morbidity by destruction of adjacent vital structures. Due to the rarity of these tumors,
evidence regarding optimal treatment protocols is drawn from case reports and single-arm series
with small patient numbers. We report a case of a patient with a desmoid tumor of the left
supraclavicular region that was diagnosed and treated in our department and a review of the current
literature.
Introduction
The fibromatoses or desmoid tumors are a group of rare
disorders arising from the connective tissue of the muscle,
the overlying fascia or aponeurosis [1]. Although they are
regarded as benign lesions, desmoid tumors are locally
infiltrative and can cause extensive morbidity by destruc-
tion of adjacent vital structures and organs [2]. Incidence is
estimated at 2.4 to 4.5 cases per million persons annually,
while most cases appear to be intra-abdominal with
only 7-15% of cases involving the head and neck [3]. The
rarity of these tumors has hindered the progress of the
studies on this disease and thus, to date, the optimal
treatment protocol for these patients remains unclear [4].
We report a case of a patient with fibromatosis of the left
supraclavicular region that was diagnosed and treated in
our department.
Case presentation
A 21-year-old Caucasian Greek male with no past medical
history, presented with an enlargement in his left supracla-
vicular region associated with numbness in his left
arm during physical activity. Upon physical examination,
there was a smooth, firm, non-tender supraclavicular mass
and no palpable lymph nodes. Neurological examination
of the upper extremities did not show any sensory or
motor deficits. Magnetic resonance imaging (MRI) of
the neck revealed an enhancing mass in the posterior
cervical triangle, extending to the thoracic cavity (Figure 1).
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were inconclusive. The patient underwent surgery, during
which the tumor was located posterior to the brachial
plexus and was extending into the thoracic cavity behind
the parietal pleural. Gross total resection of the tumor was
obtained, leaving unharmed the neural elements as well as
the large vessels of this area. The excised tumor, measuring
10 cm ¥ 8c m¥ 4.5 cm, had well defined smooth, round
borders and was relatively firm (Figure 2). Histological
examination of the mass revealed the presence of elongated
spindle-shaped cells, surrounded by abundant collagen,
features consistent with fibromatosis. Immunostaining
was positive for desmin, vimentin, non-specfic enolase
and b-catenin and negative for acinin and S-100. The
Figure 1. Magnetic resonance imaging of the neck shows on T1 (A) and T2 (B) sequencing a well-circumcised mass with
increased signal intensity in the posterior cervical triangle, extending to the thoracic cavity.
Figure 2. (A) Gross total resection of the tumor. (B) Macroscopic appearance of the excised mass.
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discharged on the 4
th postoperative day. During his follow-
up MRI study, 6 months after his operation, no evidence of
tumor recurrence were detected.
Discussion
Desmoid tumors are rare fibroblastic tumors that are
characterized by the presence of proliferating normal-
appearing fibroblastic cells in an abundant collagen stroma.
There is a female predominance while the highest incidence
arises among patients between the ages of 15 to 60 years old
[5]. Desmoids arise sporadically, nevertheless in an inci-
dence ranging from 3% to 35% these tumors can occur in
patients with familial adenomatous polyposis [6,7].
Desmoid fibromatosis may occur at abdominal, intra-
abdominal and extraabdominal locations. Extraabdominal
fibromatosis most frequently occurs in the limbs, followed
by the head and neck region [8]. Although these tumors are
benign their clinical behavior is unpredictable. Rock et al,
in a series of 194 patients with extra-abdominal desmoid
tumors, report a 68% recurrence rate at an average of
1.4 years after the first treatment [9]. Such an aggressive
behavior combined with the presence of many vital
structures in a confined area in the head and neck, consists
of a major therapeutic challenge.
At present the management of desmoid tumors includes
the use of surgery, radiation therapy (RT) as well as
cytotoxic and noncytotoxic chemotherapy. Given the
benign nature of these tumors, treatment strategies aim
at achieving local control while preserving proper function
and providing with an adequate cosmetic result [4]. When
medically and technically feasible, complete resection of
the tumor with negative microscopic margins is the first-
line treatment [10]. Nevertheless, it must be noted that the
importance of positive margin status to local recurrence
rates, is still a matter of debate. In contrast to other
published series [2,10], a study by Gronchi et al showed
that presence of microscopic disease did not affect long-
term disease-free survival in patients with primary
presentation of extra-abdominal desmoid tumors [11].
Primary RT is an appropriate alternative for patients who
are not good surgical candidates [12]. On the other hand
the use of postoperative RT is unclear. After taking under
consideration the controversy regarding the significance
of positive resection margins and the potential for late
radiation toxicity, particularly in younger patients, some
researchers advocate that RT should not be pursued in
patients with primary disease and either negative or
positive surgical margins, but only in cases with gross
residual disease [13,14]. In agreement with this approach
our patient did not receive adjuvant RT. Systemic therapy
includes a variety of noncytotoxic (tamoxifen, testolactone
and the nonsteroidal anti-inflammatory drugs) and
cytotoxic agents (methotrexate, vinblastine and doxorubi-
cin). Possible candidates for systemic therapy include
patients with Gardner’s syndrome and unresectable or
recurrent desmoid tumors, involving the mesentery [15]. It
must be emphasized that, to date, the evidence regarding
the efficacy of these agents are drawn from case reports and
single-arm series with small patient numbers [16].
In summary, desmoid tumors are rare and benign
neoplasms with a unique biologic behavior. Treatment
strategies must be individualized soas to provide adequate
local control with subsequent acceptable functional and
esthetic outcome. Despite the applied therapeutic method,
due to the high recurrence rate, these patients must be
closely followed by clinical examination and radiographic
studies.
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